Exelixis, Inc. (EXEL)

Exelixis Market Cap

Exelixis has a market cap or net worth of $10.18 billion as of May 14, 2025. Its market cap has increased by 42.73% in one year.

• Market Cap: 10.18B
• Enterprise Value: 9.34B
• 1-Year Change: 42.73%
• Ranking: #871
• Category: Large-Cap
• Stock Price: $36.95

Market Cap Chart

Since April 17, 2000, Exelixis's market cap has increased from $630.80M to $10.18B, an increase of 1,514.27%. That is a compound annual growth rate of 11.73%.

Market Cap History

Date	Market Cap	% Change
May 12, 2025	10.35B	8.84%
Dec 31, 2024	9.51B	27.47%
Dec 29, 2023	7.46B	44.19%
Dec 30, 2022	5.17B	-10.54%
Dec 31, 2021	5.78B	-7.11%
Dec 31, 2020	6.23B	16.30%
Dec 31, 2019	5.35B	-8.96%
Dec 31, 2018	5.88B	-34.61%
Dec 29, 2017	8.99B	110.58%
Dec 30, 2016	4.27B	233.29%
Dec 31, 2015	1.28B	355.89%
Dec 31, 2014	281.10M	-75.11%
Dec 31, 2013	1.13B	34.59%
Dec 31, 2012	839.00M	36.62%
Dec 30, 2011	614.10M	-31.37%
Dec 31, 2010	894.80M	13.07%
Dec 31, 2009	791.40M	49.29%
Dec 31, 2008	530.10M	-41.23%
Dec 31, 2007	902.00M	4.64%
Dec 29, 2006	862.00M	10.08%
Dec 30, 2005	783.10M	10.19%
Dec 31, 2004	710.70M	41.83%
Dec 31, 2003	501.10M	9.05%
Dec 31, 2002	459.50M	-44.16%
Dec 31, 2001	822.90M	25.02%

View and export this data all the way back to 2000. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	669.76B
Johnson & Johnson	357.16B
AbbVie	332.08B
Novo Nordisk	291.59B
UnitedHealth Group	282.47B
Abbott Laboratories	224.53B
Novartis AG	209.81B
AstraZeneca	209.59B